Effects of Developing a Mobile-based Interactive Simulation Scheme for Assisting the Personalized Hands-on Learning of Nasogastric Tube Insertion

Effects of Developing a Mobile-based Interactive Simulation Scheme for Assisting the Personalized Hands-on Learning of Nasogastric Tube Insertion: a Randomized Controlled Trial

A mobile-based interactive simulation scheme (MISS) was proposed and developed to investigate its effects on facilitating hands-on learning of nasogastric tube insertion in undergraduate medical students.

Study Overview

• Status: Completed
• Conditions: Nasogastric Tube Insertion
• Intervention / Treatment: Other: A mobile-based interactive simulation scheme (MISS)

• Study Type: Interventional
• Enrollment (Actual): 73
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Taiwan
  • Tainan, Taiwan, 704
    • National Cheng Kung University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• fifth-year undergraduate medical students
• at least 20 years old
• without any practical clinical experience

Exclusion Criteria:

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: experimental group	Other: A mobile-based interactive simulation scheme (MISS); A mobile-based interactive simulation scheme (MISS) was proposed and developed to investigate its effects on facilitating hands-on learning of NG insertion in undergraduate medical students.
No Intervention: control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The 10-item evaluation questionnaire on Nasogastric tube insertion knowledge	0-100. Zero is the worst, and 100 is the best.	one week
The self-confidence scale (C-scale)	1-5. One is high uncertainty, and five is complete certainty.	one week

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
System Usability Scale (SUS)	1-5. One is strongly disagree, and five is strongly agree.	one week
The NASA-TLX (Task load index)	1-5. One is strongly disagree, and five is strongly agree.	one week
The overall learning satisfaction	1-5 each. One is strongly disagree, and five is strongly agree. The questionnaire included 20 questions, divided into 11 categories: perceived enjoyment, comparison, diagnosis report, satisfaction, intension to use, perceived usefulness, perceived ease of use, image, output quality, result demonstrability, and cognitive load.	one week
The OSCE (Objective Structured Clinical Examination) test	0-100. Zero is the worst, and 100 is the best.	one week

Collaborators and Investigators

• Sponsor: National Cheng-Kung University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): August 17, 2020
• Primary Completion (Actual): October 17, 2020
• Study Completion (Actual): May 20, 2021

Study Registration Dates

• First Submitted: December 21, 2022
• First Submitted That Met QC Criteria: February 14, 2023
• First Posted (Actual): February 24, 2023

Study Record Updates

• Last Update Posted (Actual): February 24, 2023
• Last Update Submitted That Met QC Criteria: February 14, 2023
• Last Verified: December 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: NCKUH-B-ER-109-194

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No